Exposure to Flame Retardants Early in Pregnancy Linked to Premature Birth
News provided by
Share this article
Share this article
NEW YORK, March 10, 2021 /PRNewswire/ Expectant women are more likely to give birth early if they have high blood levels of a chemical used in flame retardants compared with those who have limited exposure, a new study finds.
These polybrominated diphenyl ethers (PBDEs) are used in the manufacture of furniture, carpeting, and other products to reduce flammability. Previous studies have found that the substances can leach into household dust and build up in the body where they may interfere with the thyroid, an organ that secretes brain-developing hormones. Childhood exposure to PBDEs has been linked to learning disabilities, autistic symptoms, and behavioral issues, among other developmental problems.
Share this article
Share this article
PASADENA, Calif., March 10, 2021 /PRNewswire/ A Kaiser Permanente study showed that one type of pneumonia vaccine, the PCV13 vaccine, may affect the course of COVID-19 for some older adult patients. The study was published in The Journal of Infectious Diseases. Kaiser Permanente members who received the PCV13 vaccine appeared to be diagnosed with COVID-19 less often, and when they were, they seemed to have less severe outcomes, overall, said the senior author, Sara Y. Tartof, PhD, MPH, a scientist with the Kaiser Permanente Southern California Department of Research & Evaluation. One of the most interesting aspects of our findings was that the patients who received PCV13 received some protection against COVID-19, while those who received PPSV23, another pneumococcal vaccine, did not.
Exposure to Flame Retardants Early in Pregnancy Linked to Premature Birth apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
February 25, 2021
Assisted by the HEART score, emergency physicians appear to be able to safely discharge patients with chest pain after just one negative conventional troponin test result, a retrospective cohort study suggests.
The 30-day rate of acute MI or cardiac mortality was similar regardless of whether patients had one troponin test or underwent serial testing in the emergency department (0.4% in both groups), researchers report.
Clinical guidelines recommend serial troponin testing in patients presenting with symptoms indicative of ACS, but these findings suggest that a single negative test when combined with risk-stratification tools like the HEART score and a physician’s clinical judgment might be good enough, senior author Adam Sharp, MD (Kaiser Permanente Southern California, Pasadena, CA), told TCTMD.
3 Things That Were Once Science Fiction That Have Now Become Science Fact – Investment Watch investmentwatchblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investmentwatchblog.com Daily Mail and Mail on Sunday newspapers.